Hims & Hers Health Stock Crashes After Earnings: Is Now the Time to Buy?

Source Motley_fool

Key Points

  • Hims & Hers Health grew its revenue by 49% last quarter.

  • The company incurred a loss, however, as its gross margins deteriorated.

  • 10 stocks we like better than Hims & Hers Health ›

Hims & Hers Health (NYSE:HIMS) stock is in free fall. The company reported earnings last week, and the results clearly didn't impress the market. The stock is now down to around the levels it was at in April, and since the start of the year, it has declined by more than 40%.

Was the earnings report really that bad for Hims & Hers stock, or is the market overreacting, and could this instead be a great buying opportunity?

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

Hims & Hers wellness products displayed on pastel retail shelves with decorative mirrors.

Image source: Getty Images.

Hims & Hers continues to generate strong revenue growth, but it posted a loss last quarter

For its September quarter, Hims & Hers reported impressive revenue growth of 49%, with its top line coming in at 890.4 million. Its subscriber count rose by 13%, and monthly revenue per average subscriber also increased by 30%.

The numbers seemed solid at first glance for the healthcare company, which offers patients access to personalized treatment options, including for GLP-1 drugs. But what's concerning is that although the growth rate is impressive, the company's bottom line isn't nearly as strong.

Hims & Hers incurred an operating loss of $66.1 million, which was a sharp reversal from a year ago when it reported a profit of $11.8 million. Not only were operating expenses higher, which investors would normally expect to see with more revenue, but its gross margin percentage worsened from 74% a year ago to 57% this past quarter. This can be a worrisome sign, as it means a smaller portion of revenue is left after cost of sales to cover its operating costs. This may be due to more aggressive pricing or product mix. Either way, it's not a great sign.

Is Hims & Hers Health stock a good buy right now?

The telehealth company has achieved impressive growth over the years, but with worsening margins and a lack of consistent profitability, the stock is a bit of a risky buy these days. Its financials aren't impressive beyond the top line, and its overall business doesn't have a sustainable competitive advantage that makes it a safe long-term investment to hold on to; its ability to succeed over the long term is by no means a sure thing, and investors shouldn't assume it'll recover from its recent downturn.

Hims & Hers isn't a stock I'd buy, as it requires incredibly high gross margins for the company to turn a profit, and in the most recent quarter, gross margin declined notably. Until and unless the company can demonstrate that it can grow profitably on a reliable basis, I'd avoid the stock.

Should you buy stock in Hims & Hers Health right now?

Before you buy stock in Hims & Hers Health, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $335,171!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,000,640!*

Now, it’s worth noting Stock Advisor’s total average return is 823% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 16, 2026.

David Jagielski, CPA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
AMD Just Had Its Biggest Run Against Nvidia Since 1999. Can It Survive Earnings?AMD outperformed Nvidia by 53.2 percentage points over five trading days, according to The Kobeissi Letter. That is the widest gap between the two chipmakers since Nvidia went public in January 1999.T
Author  Beincrypto
17 hours ago
AMD outperformed Nvidia by 53.2 percentage points over five trading days, according to The Kobeissi Letter. That is the widest gap between the two chipmakers since Nvidia went public in January 1999.T
placeholder
3 Key Events in the Coming Week That Could Move AI Stocks and CryptoNvidia earnings, Fed minutes, and Anthropic’s IPO all land between Tuesday and Thursday in the coming week. Each will test an AI selloff that has also spilled into crypto.Rates add a second layer of r
Author  Beincrypto
17 hours ago
Nvidia earnings, Fed minutes, and Anthropic’s IPO all land between Tuesday and Thursday in the coming week. Each will test an AI selloff that has also spilled into crypto.Rates add a second layer of r
placeholder
Weekly Market Wrap: Nvidia Lost Its CEO, but AI Stocks Found New LeadersNvidia’s leadership shock has put the AI trade in focus, but other technology stocks are emerging as new market leaders. Explore this week’s key market moves, shifting investor sentiment and what Australian traders should watch next.
Author  Mark Garro
17 hours ago
Nvidia’s leadership shock has put the AI trade in focus, but other technology stocks are emerging as new market leaders. Explore this week’s key market moves, shifting investor sentiment and what Australian traders should watch next.
placeholder
Bitcoin’s Fall to $62,000 Sparks Market Manipulation ClaimsBitcoin plunged to nearly $62,000 on November 15, its lowest level since July. The drop wiped out months of gains and triggered more than $2 billion in liquidations.Now, several analysts claim that la
Author  Beincrypto
17 hours ago
Bitcoin plunged to nearly $62,000 on November 15, its lowest level since July. The drop wiped out months of gains and triggered more than $2 billion in liquidations.Now, several analysts claim that la
placeholder
Bitcoin Loses Key 200-Day Average: Is $67,000 Next?Bitcoin price fell below its 200-day moving average of $73,137 on Thursday. It’s one of the most closely watched indicators in crypto because it helps investors understand whether Bitcoin’s long-term
Author  Beincrypto
Nov 13, Fri
Bitcoin price fell below its 200-day moving average of $73,137 on Thursday. It’s one of the most closely watched indicators in crypto because it helps investors understand whether Bitcoin’s long-term
goTop
quote